Saving changes...

Done

Error

Novel Biologicals for Asthma and Allergic Rhinosinusitis

Novel Biologicals for Asthma and Allergic Rhinosinusitis

Novel Biologicals for Asthma and Allergic Rhinosinusitis

PRof. Cezmi A. Akdis (MD FAAAAI), Prof. Claus Bachert (MD PhD), and Dr. Sally E. Wenzel (MD FAAAAI)
PRof. Cezmi A. Akdis (MD FAAAAI), Prof. Claus Bachert (MD PhD), and Dr. Sally E. Wenzel (MD FAAAAI)
on behalf of American Academy of Allergy Asthma & Immunology

$15.00 $ 15.00 $ 15.00

$15.00 $ 15.00 $ 15.00

$ 15.00 $ 15.00 $ 15.00
$ 15.00 $ 15.00 $ 15.00
Normal Price: $15.00 $15.00

Review:

Launch date: 29 Jun 2018
Expiry Date:

Last updated: 22 Aug 2018

Reference: 190487

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This session will aim to inform about two major therapeutic strategies, namely biologicals and allergen-speciffic immunothrapy for asthma and allergic rhinits and their mechanisms of action. Allergen-specific immunotherapy, aims to induce specific immune tolerance and has a long-term disease-modifying effect. The second approach is the use of biological immune response modifiers to decrease pathological immune responses targeting a dominant inflammatory mechanism, such as IgE, IL-5, IL-13.

Objectives

Discuss novel biologicals in allergy and immunology
Upon completion of this activity, participants will be able to discuss novel biologicals in allergy and immunology.
Discuss mechanisms underlying novel immunologic therapies
Upon completion of this activity, participants will be able to discuss mechanisms underlying novel immunologic therapies.
PRof. Cezmi A. Akdis (MD FAAAAI), Prof. Claus Bachert (MD PhD), and Dr. Sally E. Wenzel (MD FAAAAI)

Author Information Play Video Bio

PRof. Cezmi A. Akdis (MD FAAAAI), Prof. Claus Bachert (MD PhD), and Dr. Sally E. Wenzel (MD FAAAAI)
on behalf of American Academy of Allergy Asthma & Immunology

Prof. Cezmi A. Akdis, MD FAAAAI, Swiss Institute of Allergy and Asthma Research, Davos, Switzerland

Prof. Claus Bachert, MD PhD, Upper Airway Research Laboratory (URL), Ghent University Hospital, Ghent, Belgium

Dr. Sally E. Wenzel, MD FAAAAI, University of Pittsburgh Medical Center NW, Pittsburgh, PA

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 1.25 Credits
  • California Board of Registered Nursing (CBRN)
  • 1.25 Hours

Faculty and Disclosures

Cezmi A. Akdis, MD FAAAAI

Cezmi A. Akdis, MD FAAAAI

Potential Conflict

Advisory Board: Circassia (United
Kingdom)
Advisory Board: Allergopharma (Germany)
Advisory Board: Novartis (Basel,
Switzerland)
Advisory Board: Teva (Amsterdam, the
Netherlands)
Advisory Board: Anergis (Lausanne,
Switzerland)
Advisory Board Member and Shareholder
(Ongoing): Davos Diagnostics (Davos,
Switzerland)
Claus Bachert, MD PhD

Claus Bachert, MD PhD

Potential Conflict

ALK (Ongoing): speaker
Allergopharma: speaker, board
Bionorica (Ongoing): speaker, board
Genentech: board
Meda (Ongoing): speaker, board
MSD (Ongoing): speaker
Novartis (Ongoing): board
Stallergenes (Ongoing): speaker
Uriach (Ongoing): speaker, board
Sally E. Wenzel, MD FAAAAI

Sally E. Wenzel, MD FAAAAI

Potential Conflict Consultant: AstraZneneca
Consultant: Boehringer Ingelheim
Consultant: GSK
Research Grant: Boehringer Ingelheim
Research Grant: Sanofi Aventis
Research Grant: AstraZeneca
Research Grant: GSK
Research Grant: Genentech
AstraZeneca (Ongoing): Advisory Board
(Airfare+Honorarium)

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error